has changed the 🌏🌍🌎 in so many ways, bringing us closer together and reaffirming the importance of . Don't miss this video showing the key moments so far as WHO works with partners worldwide to fight the pandemic and save lives.

Timely data is vital to understand the true scale of the pandemic. Rapid mortality surveillance is an important tool to capture mortality from all causes in all settings.

Not everything you hear about is true. For accurate information ✔️ Find official advice from your country’s public health authority or ✔️ the World Health Organization

Stay healthy this : 🍲🥗 Maintain a healthy balanced diet 💧🍅 Follow food safety measures 📲🤳 Stay connected with your loved ones 🏃‍♀️🤸‍♂️ Stay active 🛌💤 Sleep well

Muchos niños necesitan apoyo para adaptarse a los cambios que ha traído en nuestro día a día la . Este libro de cuentos de la les ayuda a aceptar esa nueva realidad.

The document provided practical guidance on implementing rapid mortality surveillance and measuring excess mortality in the context of pandemic. Big focus on implementation in low-resource settings

Countries need real-time mortality data for an effective response. WHO together with & released a new technical package on rapid mortality surveillance

La ha cambiado el 🌏🌍🌎 de muchas formas distintas, uniéndonos más y reafirmando la importancia de la . Vea este video que resume el trabajo de la OMS con sus asociados de todo el mundo para luchar contra la pandemia y salvar vidas.

"WHO will provide further updates as we know more. And we will continue to work night and day for solutions, science and solidarity"-

"The other arms of the trial are continuing. This concern relates to the use of hydroxychloroquine and chloraquine in . I wish to reiterate that these drugs are accepted as generally safe for use in patients with autoimmune diseases or malaria"-

"The Executive Group has implemented a temporary pause of the hydroxychloroquine arm within the Solidarity Trial while the data is reviewed by the Data Safety Monitoring Board"-

"The review will consider data collected so far in the Solidarity Trial and, in particular robust randomised available data, to adequately evaluate the potential benefits and harms from this drug"-

"The Executive Group of the Solidarity Trial, representing 10 of the participating countries, met on Saturday and has agreed to review a comprehensive analysis and critical appraisal of all evidence available globally"-

"The authors reported that among patients receiving the drug, when used alone or with a macrolide, they estimated a higher mortality rate"-

"On Friday, published an observational study on hydroxycholoroquine & chloraquine & its effects on patients that have been hospitalised"-

"Over 400 hospitals in 35 countries are actively recruiting patients & nearly 3500 patients have been enrolled from 17 countries"-

"As part of our continued response to the pandemic globally, WHO continues to work aggressively on R&D. As you know, more than two months ago we initiated the Solidarity Trial, to evaluate the safety and efficacy of four drugs and drug combinations against "-

"And disruption to essential health services, such as vaccination campaigns and care for malaria, HIV and other diseases pose a huge risk"-

"However, we still see gaps and vulnerabilities. Only 19% of countries in the region have an infection prevention and control programme and standards for water, sanitation and hygiene in health facilities"-

"WHO continues to support Africa with other life-saving supplies. As of last week, we've shipping millions of personal protective equipment & lab tests to 52 African countries. In the coming weeks we plan further shipments of PPE, oxygen concentrators & lab tests"-

End of content

No more pages to load